Publication Type:

Journal Article

Source:

Indian Journal of Clinical Biochemistry, Volume 13, Number 2, p.126-128 (1998)

URL:

http://www.scopus.com/inward/record.url?eid=2-s2.0-77949937455&partnerID=40&md5=5ae344b455caf1441892581a39d4d306

Abstract:

In a pilot study with five oral cancer patients undergoing radiotherapy (RT) three were given Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) as a protective agent to reduce the mucosal inflammation during radiotherapy. The myeloperoxidase (MPO) enzyme activity in WBC was quantitated. The three patients snowed a significant increase in the MPO activity when compared with two untreated controls indicating the efficacy of GM-CSF as a protective agent. It is suggested that further detailed studies with larger number of patients would be useful.

Notes:

cited By 0

Cite this Research Publication

N. Ananth, ,, Dr. Damodaran Vasudevan, Souza, V. D., Rao, A. V., and Nambiar, D., “Enhancement of myeloperoxidase activity in wbcs in oral cancer patients treated with granulocyte macrophage colony stimulating factor (GM-CSF) - A pilot study”, Indian Journal of Clinical Biochemistry, vol. 13, pp. 126-128, 1998.

207
PROGRAMS
OFFERED
5
AMRITA
CAMPUSES
15
CONSTITUENT
SCHOOLS
A
GRADE BY
NAAC, MHRD
9th
RANK(INDIA):
NIRF 2017
150+
INTERNATIONAL
PARTNERS